Extracted product is non-activated, full spectrum and is comprised of integrated phytocannabinoid and accompanying, consequential phytocompounds. Each batch duplicates the comprehensive phytocannabinoid and phytocompounds expressed by the specific genetic variant of the cultivated hemp. Typical profiles include 80-95% acidic phytocannabinoids, in addition to flavonoids, terpenes and saponins.
Commonly available research suggests that each phytocannabinoid has its own potential therapeutic properties in interacting with the body’s endocannabinoid system. Interrelated phytocompounds are shown through research to also have potential therapeutic properties of their own. A few, primary examples include:
Cannabidiolic acid (CBDa) has been examined for its presumed analgesic properties as well as its supposed anti-tumor properties in specific types of breast cancer
Cannabigerolic acid (CBGa) has been studied for its potential ability to diminish symptoms related to irritable bowel diseases
Tetrahydrocannabinolic acid (THCa), a non-psychoactive phytocannabinoid, has been investigated for its anti-nausea properties
Saponins may have plasma cholesterol lowering effects as well as having the potential for diminishing the effects of many chronic diseases
Flavonoids have been shown to have significant potential in treating pancreatic cancer
Terpenes have shown potential in anti-inflammatory and antinociceptive activity
The Entourage Effect is the scientific community’s holistic supposition of a system’s optimal efficacy being derived from the entirety of its collective coordination, especially as it relates to the complete phytocompounds derived from hemp. In simple terms, the entourage effect is the synergistic interaction of phytocannabinoids, flavonoids, terpenes, saponins and other important, individual phytocompounds present in hemp. In principle, the entourage effect is the magnification of therapeutic benefits from the collective combination of these compounds.